Learn More
Description
The p53 protein is critical to regulation of normal cell growth and proliferation and is a suppressor of tumor cell proliferation. Inactivation of p53 by a number of mechanisms, such as missense mutations or interaction with oncogenic viral or cellular proteins, can result in tumor progression. Mutations and/or allelic loss of the p53 gene are associated with a wide variety of human tumors. Known to have a role in transcriptional regulation, p53 suppresses various promoters containing TATA elements in an apparently sequence-independent fashion. p53 also binds to DNA in a sequence-specific manner via recognition of a 20-bp consensus-binding site. This interaction stimulates the expression of genes downstream of the p53 binding site. A number of genes that contain p53-binding sites have been identified, including MDM2, GADD45, and muscle creatine kinase. Post-translational acetylation of p53 enhances its DNA-binding activity. There are multiple factors that affect p53 acetylation, thereby modulating cellular proliferation and apoptosis.
The L82-51 monoclonal antibody recognizes acetylated lysine 382 (acK382) in the C-terminal region of p53.
Host Species: Mouse
Clone: L82-51
Isotype: IgG1 κ
Species Reactivity: Human
Immunogen: Human p53 acetylated Peptide
Intracellular Staining
Specifications
Specifications
| Antigen | p53 (acK382) |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | L82-51 |
| Conjugate | Alexa Fluor 647 |
| Description | TP53 (acK382) |
| Formulation | Aqueous buffered solution containing BSA and ≤0.09% sodium azide. |
| Host Species | Mouse |
| Immunogen | Human p53 acetylated Peptide |
| Purification Method | Affinity Purified |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.